Middle meningeal artery embolization for chronic subdural hematoma using Nester pushable coils versus Onyx: a multicenter propensity score-matched analysis.

Publication/Presentation Date

1-30-2026

Abstract

BACKGROUND: Middle meningeal artery embolization (MMAE) has been shown to be an efficacious treatment for chronic subdural hematomas (cSDH). Liquid or particulate embolic agents are most commonly used, although coil embolization offers proximal vessel occlusions that may provide comparable efficacy. This multicenter propensity score-matched study compares outcomes of MMAE performed with Nester pushable coils versus Onyx.

METHODS: We retrospectively reviewed patients that underwent MMAE with either Nester coils or Onyx at two institutions between March 2019 and February 2025. Propensity score matching (1:1) was performed based on patient and hematoma characteristics. Primary outcomes included radiologic improvement or need for surgical rescue. Secondary outcomes included complication rate and procedure time.

RESULTS: A total of 183 patients were included (91 Nester coil, 92 Onyx) with similar baseline characteristics. More patients incurred general anesthesia for Onyx embolization compared with coiling (60.9% vs 15.4%; p

CONCLUSIONS: Embolization using Nester pushable coils yields similar clinical outcomes to Onyx. Pushable coils are safe, efficient, and allow for shorter procedural times, providing an effective, cost-efficient option for cSDH.

ISSN

1759-8486

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

41617492

Department(s)

Administration and Leadership

Document Type

Article

Link to Full Text

Share

COinS